Investing

Top Analyst Upgrades and Downgrades: Apple, Baker Hughes, Biogen, FedEx, Intel, Micron, Roku, Shake Shack and More

Insys Therapeutics Inc. (NASDAQ: INSY) was started with a Buy rating and assigned an $11 price target (versus a $4.35 close) at Janney, with the firm noting that its transformation to focus on R&D should bring a higher value to its shares.

Intel Corp. (NASDAQ: INTC) was maintained as Equal Weight but the target price was raised to $55 from $54 at Morgan Stanley.

Match Group Inc. (NASDAQ: MTCH) was started with a Hold rating and assigned a $47 target price (versus a $41.95 close) at SunTrust Robinson Humphrey.

Medtronic PLC (NYSE: MDT) was raised to Overweight from Neutral and the price target was raised to $109 from $100 at JPMorgan.

Micron Technology Inc. (NASDAQ: MU) was up 0.7% at $34.11 ahead of earnings, but the stock was last seen down 7.6% at $31.50 afterward. Its prior 52-week low was $33.60, and its consensus target price ahead of the report was $57.00. Analysts have slashed their targets yet again, based on the expectations for 2019: KeyBanc (Overweight) to $45 from $61, Wells Fargo (Outperform) to $50 from $63, MKM Partners (Buy) to $44 from $50 and Barclays (Overweight) to $46 from $50. Needham downgraded Micron to Hold from Buy.

NOW Inc. (NYSE: DNOW) was downgraded to Hold from Buy and the target price was lowered to $13 from $17 (versus an $11.78 close) at Stifel.

Rent-A-Center Inc. (NASDAQ: RCII) was raised to Outperform from Market Perform with a $16 price target at Raymond James.

Roku Inc. (NASDAQ: ROKU) was maintained as Overweight but the price target was slashed to $59 from $81 (versus a $31.34 close) at KeyBanc Capital Markets. It has a consensus analyst target of $62.15 and a 52-week trading range of $29.01 to $77.57.

Shake Shack Inc. (NYSE: SHAK) was raised to Hold from Underperform at Jefferies. The stock was down 1.5% at $45.08 on Tuesday, in a 52-week range of $36.58 to $70.12.

Stifel Financial Corp. (NYSE: SF) was downgraded to Market Perform from Outperform at Wells Fargo.

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) was maintained as Overweight but the price target was trimmed to $210 from $211 at Morgan Stanley.

WisdomTree Investments Inc. (NASDAQ: WETF) was raised to Neutral from Sell and the price target was raised to $6.50 from $6.00 (versus a $6.46 close) at Citigroup.

Xilinx Inc. (NASDAQ: XLNX) was reiterated as Overweight and the price target was raised to $98 from $87 (versus an $89.23 close) at Morgan Stanley.

Xylem Inc. (NYSE: XYL) was raised to Buy from Hold with a $75 price target (versus a $64.39 close) at Stifel.

Tuesday’s top analyst calls were in shares of Abbott Laboratories, Albermarle, Boston Scientific, BP, Embraer, Intuit, Marathon Oil, Norfolk Southern and many more companies.

Sponsored: Tips for Investing

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.